Pharmaceuticals Companies By Roa

Return On Asset
ROAEfficiencyMarket RiskExp Return
1NVO Novo Nordisk AS
0.22
(0.07)
 2.83 
(0.20)
2SIGA SIGA Technologies
0.18
(0.01)
 2.43 
(0.03)
3LLY Eli Lilly and
0.15
 0.05 
 1.97 
 0.11 
4ZTS Zoetis Inc
0.15
 0.00 
 1.64 
 0.01 
5MRK Merck Company
0.14
(0.05)
 1.72 
(0.08)
6HRMY Harmony Biosciences Holdings
0.13
 0.01 
 3.03 
 0.02 
7CORT Corcept Therapeutics Incorporated
0.12
 0.08 
 3.59 
 0.30 
8RDY Dr Reddys Laboratories
0.1
(0.12)
 1.56 
(0.19)
9NVS Novartis AG ADR
0.1
 0.21 
 1.34 
 0.28 
10COLL Collegium Pharmaceutical
0.0889
 0.03 
 2.67 
 0.08 
11INVA Innoviva
0.0888
(0.05)
 0.92 
(0.04)
12AMPH Amphastar P
0.0831
(0.23)
 2.34 
(0.55)
13JNJ Johnson Johnson
0.0813
 0.19 
 1.13 
 0.22 
14AZN AstraZeneca PLC ADR
0.0788
 0.20 
 1.14 
 0.23 
15OGN Organon Co
0.0739
 0.05 
 2.75 
 0.14 
16BMY Bristol Myers Squibb
0.0655
 0.08 
 1.59 
 0.13 
17GSK GlaxoSmithKline PLC ADR
0.0653
 0.16 
 1.73 
 0.27 
18AMRX Amneal Pharmaceuticals, Class
0.0624
 0.10 
 1.95 
 0.20 
19PBH Prestige Brand Holdings
0.0619
 0.06 
 2.38 
 0.14 
20PAHC Phibro Animal Health
0.056
 0.02 
 3.27 
 0.08 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time. Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.